Literature DB >> 32273606

Spread of SARS-CoV-2.

Hannah Stower1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32273606     DOI: 10.1038/s41591-020-0850-3

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  8 in total

1.  Effectiveness of Integrative Medicine in COVID-19?

Authors:  Gerhard Litscher
Journal:  Med Acupunct       Date:  2020-06-16

2.  Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.

Authors:  Ramesh K Paidi; Malabendu Jana; Rama K Mishra; Debashis Dutta; Kalipada Pahan
Journal:  J Immunol       Date:  2021-10-13       Impact factor: 5.422

Review 3.  An overview of key potential therapeutic strategies for combat in the COVID-19 battle.

Authors:  Gaurav Das; Surojit Ghosh; Shubham Garg; Satyajit Ghosh; Aniket Jana; Ramkamal Samat; Nabanita Mukherjee; Rajsekhar Roy; Surajit Ghosh
Journal:  RSC Adv       Date:  2020-07-28       Impact factor: 4.036

4.  Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.

Authors:  Hanning Liu; Shujie Gai; Xiaoyi Wang; Juntong Zeng; Cheng Sun; Yan Zhao; Zhe Zheng
Journal:  Cardiovasc Res       Date:  2020-08-01       Impact factor: 10.787

5.  ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy.

Authors:  Ramesh K Paidi; Malabendu Jana; Rama K Mishra; Debashis Dutta; Sumita Raha; Kalipada Pahan
Journal:  J Neuroimmune Pharmacol       Date:  2021-01-11       Impact factor: 7.285

6.  Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses.

Authors:  Ramesh Kumar Paidi; Malabendu Jana; Sumita Raha; Mary McKay; Monica Sheinin; Rama K Mishra; Kalipada Pahan
Journal:  J Neuroimmune Pharmacol       Date:  2021-10-22       Impact factor: 7.285

7.  Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19).

Authors:  Wei Wang; Wei Zhang; Jingjing Zhang; Ji He; Faming Zhu
Journal:  HLA       Date:  2020-06-02       Impact factor: 8.762

Review 8.  Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?

Authors:  Priyanka Pahan; Kalipada Pahan
Journal:  J Neuroimmune Pharmacol       Date:  2020-05-15       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.